Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
To access this article, please choose from the options below
PII: S0959-8049(01)00306-9
doi:10.1016/S0959-8049(01)00306-9
© 2001 Elsevier Science Ltd. All rights reserved.
